Here are relevant reports on : human-capital-management-hcm-market
-
Human Centric Lighting Market by Offering (Hardware (Lighting fixtures and Lighting Controllers), Software, and Services), Installation Type (New Installations and Retrofit Installations), Application, and Geography - Global Forecast to 2036
The human centric lighting market was valued at USD 3.66 billion in 2024 and is projected to reach USD 25.25 billion by 2036, growing at a CAGR of 17.1% from 2025 to 2036 The growth of the human centric lighting market is driven by the high adoption of LED lighting solutions; initiatives toward establishing smart cities; and the rising in demand for energy-efficient lighting solutions. The implementation of wireless technology for LED lighting is expected to provide huge growth opportunities to market players. The human centric lighting market is currently dominated by Signify Lighting NV (Netherlands), OSRAM Licht AG (Germany), Acuity Brands, Inc. (US), Cree, Inc. (US), Legrand SA (France), Hubbell Inc. (US), Zumtobel Group AG (Austria), Wipro Enterprises (P) Ltd. (India), Glamox AS (Norway), and Lutron Electronics Co., Inc. (US). A few of the major strategies adopted by these players to compete in the human centric lighting market include product launches and developments, partnerships, and mergers and acquisitions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cognitive Computing Market by Component, Deployment Mode, Business Function, Application (IVA and Chatbot and Behavioral Analysis), Technology (Human Computer Interface and Deep Learning), Industry Vertical, and Region - Global Forecast to 2025
The Cognitive Computing Market is expected to grow from USD 20.5 billion in 2020 to USD 77.5 billion by 2025, at a CAGR of 30.5% during the forecast period. The report includes the study of the key players offering cognitive computing solutions and services. The major vendors Microsoft (US), Google (US), IBM (US), Numenta (US), SAS Institute (US), AWS (US), Enterra Solutions (US), CognitiveScale (US), SparkCognition (US), TCS (India), Expert System (US), Cisco (US), Virtusa (US), Cognitive Software Group (Australia), Red Skios (Spain), Artificial Solutions (Sweden), Acuiti (Australia), Vantage Labs (US), E-Zest (India) and Burstiq (US). It also includes an in-depth competitive analysis of the key players in the cognitive computing market, along with their company profiles, business overviews, product offerings, recent developments, and market strategies.
- Published: March 2020
- Price: $ 4950
- TOC Available:
-
Eye Tracking Market by Offering (Hardware, Software, Services), Tracking Type (Remote and Mobile), Application (Assistive Communication, and Human Behavior & Market Research), Vertical, and Geography- Global Forecast to 2025
The Eye Tracking Market is expected to grow from USD 368 million in 2020 to USD 1,098 million by 2025, at a CAGR of 24.5% during the forecast period. A few key players operating in the eye tracking market are Tobii (Sweden), EyeTracking (US), SR Research (Canada), Seeing Machines (Australia), PRS IN VIVO (France), Smart Eye (Sweden), EyeTech Digital Systems (US), Eyegaze (US), Ergoneers (Germany), ISCAN (US), iMotions (Denmark), and Lumen Research (UK).
- Published: July 2020
- Price: $ 4950
- TOC Available:
-
AI Avatar Market by Platform (Digital Human, 3D & Metaverse Avatars, Stylized Avatars), Type (Interactive Avatars, Noninteractive Avatars), Application (Virtual Assistant, Characters, Influencer, Companion, Podcaster & VTuber) - Global Forecast to 2032
The AI avatar market is expanding rapidly, with a projected market size anticipated to rise from USD 0.80 billion in 2025 to USD 5.93 billion by 2032, featuring a CAGR of 33.1%. The major players in the AI avatar market include Synthesia (UK), HeyGen (US), D-ID (Israel), Akool (US), Veritone (US), NVIDIA (US), AWS (US), Meta (US), Vyond (US), and Soul Machines (US).
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)
The global single-cell analysis market, valued at US$3.55 billion in 2024, stood at US$3.81 billion in 2025 and is projected to advance at a resilient CAGR of 14.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.56 billion by the end of the period.Growth in this market can be attributed to factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026
The global artificial cornea and corneal implant market in terms of revenue was estimated to be worth $418 million in 2021 and is poised to reach $599 million by 2026, growing at a CAGR of 7.4% from 2021 to 2026. Some of the major players operating in the market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US) and L V Prasad Eye Institute (LVPEI, India).
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Choline Chloride Market by End-User (Poultry feed, Swine feed, Ruminant feed, Aqua feed & others, Human nutrition and Oil & Gas, and Misc. applications), and Geography - Regional Trends & Forecast to 2019
Choline chloride is an organic compound. It is used in the animal feed additive. It is mainly related with the metabolism and act as methyl donor. It builds and maintains cell structure and function. It is very essential for growing animal and its feed intake helps in preventing perosis, conditions like fatty liver syndrome, etc. Apart from animal feed additive, it is also used in human nutrition and as a clay stabilizer in oil and gas industry.
- Published: April 2014
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
